title: Blood coagulation and fibrinolysis in obese NIDDM patients.
abstract: Four group of age- and sex-matched patients were studied: 1. nondiabetic subjects (n = 20) with a body mass index (BMI) < 25 Kg/m2 (lean control subjects); 2. obese non diabetic subjects (n = 22) with a BMI > 30 Kg/m2 (obese control subjects); 3. lean NIDDM subjects (n = 22); and 4. obese NIDDM subjects (n = 24). We determined: total cholesterol, triglycerides, HDL-cholesterol, blood glucose, Apolipoproteins A1 and B, insulin, Lp(a), Factor VII, fibrinogen, plasminogen, t-PA(Ag) pre and post venous occlusion (VO) and PAI activity pre and post VO. In addition to metabolic abnormalities obese non diabetic subjects and lean and obese NIDDM patients displayed significantly higher levels of fibrinogen, Factor VII, plasminogen, PAI pre and post VO and tPA(Ag) pre VO and significantly lower levels of t-PA(Ag) post VO. Our findings demonstrate an impairment of the haemostatic and fibrinolytic mechanisms which may be a key role in the pathogenesis of atherosclerotic vascular complications in obesity and in NIDDM.
authors.affiliation: Institute of Clinical Medicine, University of Palermo, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Avellone
authors.forename: V
authors.initials: V
authors.lastname: Di Garbo
authors.forename: R
authors.initials: R
authors.lastname: Cordova
authors.forename: G
authors.initials: G
authors.lastname: Rotolo
authors.forename: G
authors.initials: G
authors.lastname: Abruzzese
authors.forename: G
authors.initials: G
authors.lastname: Raneli
authors.forename: R
authors.initials: R
authors.lastname: De Simone
authors.forename: G D
authors.initials: GD
authors.lastname: Bompiani
mesh_terms: D016632:Apolipoprotein A-I / Q000097:blood; D001055:Apolipoproteins B / Q000097:blood; D001777:Blood Coagulation; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005167:Factor VII / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006801:Humans; D007328:Insulin / Q000097:blood; D017270:Lipoprotein(a) / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood*; D010958:Plasminogen / Q000032:analysis; D012016:Reference Values; D010959:Tissue Plasminogen Activator / Q000097:blood; D014280:Triglycerides / Q000097:blood
chemical_list: D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D001786:Blood Glucose; D008076:Cholesterol, HDL; D007328:Insulin; D017270:Lipoprotein(a); D014280:Triglycerides; D005167:Factor VII; D005340:Fibrinogen; D010958:Plasminogen; D002784:Cholesterol; D010959:Tissue Plasminogen Activator